Solara Active Pharma share price zooms 16% on Q2 turnaround; H1 net up 103x
A quarterly results development with market-wide reach.
· Business Standard Mkts
Solara Active Pharma Sciences reported a consolidated net profit of ₹28.59 crore in Q2FY27 and ₹44.70 crore in H1FY27. It posted a loss of ₹9.29 crore in Q2FY26 and profit of ₹0.42 crore in H1FY26.
Key facts
- Period
- Q2FY27 and Q2FY26
The analysis
Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- Sectors in the story: Pharma & Healthcare.
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Sun Pharma Q2 profit falls 36% as litigation costs hit earnings
Max Healthcare Q2 net profit falls 15.6% on higher operating, tax expenses
Max Healthcare Q2 PAT rises 10% to ₹448 cr on higher bed occupancy
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY